Macquarie Sets XPeng Inc ADR (NYSE:XPEV) Stock to “a Neutral”
Macquarie raised the price target for the XPeng Inc ADR (NYSE:XPEV) stock to “a Neutral”. The rating was released on April 15, 2024, according to finviz. The research report from CLSA has upgraded the stock from Outperform to Buy, with a price target set at $24. The stock was upgraded by HSBC Securities, who disclosed […]
XPeng Inc ADR (NYSE:XPEV) stock Posted Operating Margin of -37.43 percent in Last Year: Is Admissible?
Macquarie raised the price target for the XPeng Inc ADR (NYSE:XPEV) stock to “a Neutral”. The rating was released on April 15, 2024, according to finviz. The research report from CLSA has upgraded the stock from Outperform to Buy, with a price target set at $24. The stock was upgraded by HSBC Securities, who disclosed […]
Top-line Growth is Likely to Be Driven by XPeng Inc ADR (XPEV) Stock
Macquarie raised the price target for the XPeng Inc ADR (NYSE:XPEV) stock to “a Neutral”. The rating was released on April 15, 2024, according to finviz. The research report from CLSA has upgraded the stock from Outperform to Buy, with a price target set at $24. The stock was upgraded by HSBC Securities, who disclosed […]
XPeng Inc ADR (NYSE:XPEV) Stock Price Settled at $7.18: What’s Resulting?
Macquarie raised the price target for the XPeng Inc ADR (NYSE:XPEV) stock to “a Neutral”. The rating was released on April 15, 2024, according to finviz. The research report from CLSA has upgraded the stock from Outperform to Buy, with a price target set at $24. The stock was upgraded by HSBC Securities, who disclosed […]
Is XPeng Inc ADR (XPEV) Stock A Better Investment Than Its Rivals?
Macquarie raised the price target for the XPeng Inc ADR (NYSE:XPEV) stock to “a Neutral”. The rating was released on April 15, 2024, according to finviz. The research report from CLSA has upgraded the stock from Outperform to Buy, with a price target set at $24. The stock was upgraded by HSBC Securities, who disclosed […]
